Events

Bio€quity Europe is the premier annual gathering of the corporate and investment communities for the global life sciences industry. Co-organized by BioCentury and EBD Group, it brings together biotech CEOs, venture capitalists, private equity investors, pharma BD&L leaders and financial dealmakers to network, partner and debate the critical issues shaping the biotech industry.

Now in its 26th edition, Bio€quity Europe is the longest-running and most senior-level biotech investor conference in Europe. No biotech event attracts a higher concentration of investors. Although anchored in Europe, Bio€quity Europe is a truly global event, with investors and dealmakers attending from Europe, the United States and Asia. Every European biotech that aspires to globalize — whether by attracting U.S. investors for a NASDAQ IPO, licensing assets to global pharma, or commercializing in the U.S., the world’s largest pharma market — will find the right people in the room at Bio€quity Europe.

Past Faculty and delegates have included leaders from Sofinnova Partners, Forbion, Jeito Capital, Gilde Healthcare, EQT Life Sciences, Kurma Partners, Andera Partners, RA Capital, OrbiMed, Novo Holdings, LSP, BioMedPartners, MSD, Bayer, Novartis, Roche, Sanofi, Johnson & Johnson, MoonLake Immunotherapeutics, Candel Therapeutics and many more.

The LSX Nordic Congress is the leading partnering, strategy, and investment event serving the Nordic and Baltic region, with qualified 1:1 partnering at its core.

We gather senior life science industry decision-makers from the region’s most innovative biotech, medtech, and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs.

Together, they share best practices, forge partnerships, and discuss investment – to revolutionise healthcare.